Wang Xue-qing, Dai Jun-dong, Zhang Qiang, Zhang Tao, Xia Gui-min
Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100083, China.
Yao Xue Xue Bao. 2004 Jun;39(6):463-6.
To study the preparation of hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles and compare its pharmacokinetic characteristics with Neoral.
HPMCP nanoparticles loaded cyclosporine A were prepared by solvent-nonsolvent method. CyA-HP50 nanoparticles, CyA-HP55 nanoparticles and Neoral were orally administered at the dosage of 15 mg x kg(-1) to rats. The CyA concentration in blood were determined by HPLC. Pharmacokinetic parameters were calculated by 3P97 program.
The concentration-time data of the three preparations were best fit by two compartment model. The relative bioavailability of CyA-HP50 and CyA-HP55 nanoparticles calculated by the AUC0-72 were 82.3% and 119.6%, bioequivalent to the reference of Neoral. The relative bioavailability of CyA-HP55 nanoparticles was 145.3% of CyA-HP50 nanoparticles.
CyA HPMCP nanoparticles could be prepared easily and reproducibly. It was found that the oral absorption of CyA can be increased by using the HPMCP nanoparticles.
研究邻苯二甲酸羟丙甲纤维素(HPMCP)纳米粒的制备,并将其药代动力学特征与新山地明进行比较。
采用溶剂-非溶剂法制备载环孢素A的HPMCP纳米粒。将环孢素A-HP50纳米粒、环孢素A-HP55纳米粒和新山地明以15mg·kg⁻¹的剂量口服给予大鼠。采用高效液相色谱法测定血中环孢素A的浓度。用3P97程序计算药代动力学参数。
三种制剂的浓度-时间数据均最符合二室模型。根据AUC0-72计算,环孢素A-HP50和环孢素A-HP55纳米粒的相对生物利用度分别为82.3%和119.6%,与新山地明参比制剂生物等效。环孢素A-HP55纳米粒的相对生物利用度是环孢素A-HP50纳米粒的145.3%。
环孢素A-HPMCP纳米粒制备简便、重现性好。发现使用HPMCP纳米粒可提高环孢素A的口服吸收。